MMP-9 degrades tight junction proteins in a variety of neurological diseases, including ischemic stroke, traumatic brain injury, and SAH (Egashira et al., 2015; Lu et al., 2018; Yang et al., 2020). Here, MMP9 is linked to nervous system disorder.